SynthesisFrontiers in psychiatry2026

Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis.

Jingqiang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.